查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1697961

全球精神病數位生物標記市場：市場規模、佔有率、趨勢、行業分析（按類型、醫療程序、最終用途和地區）、未來預測（2025-2034）

Psychiatric Digital Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Type, Clinical Practice, End Use, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，全球精神病數位生物標記市場規模預計到 2034 年將達到 5,543,770 億美元。該研究報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

精神病數位生物標記是透過數位裝置收集的客觀、可量化的生理和行為數據點，用於評估心理健康狀況。在人工智慧、穿戴式健康技術和基於行動的心理健康監測的推動下，精神病數位生物標記市場正在經歷顯著擴張。憂鬱症、精神分裂症和焦慮症等精神疾病的盛行率不斷上升，推動了精神病數位生物標記市場的需求，臨床醫生和研究人員正在尋求數據驅動的即時監測工具，以實現準確診斷和個人化治療。此外，生物感測器越來越多地融入智慧手錶、行動應用程式和人工智慧分析中，以增強遠端患者監控和臨床決策，也推動了市場的成長。

精神病數位生物標記產業的趨勢表明，人們正在轉向利用機器學習演算法來分析行為模式、音訊生物標記和生理訊號，以提高預測準確性和早期幹預的能力。此外，製藥和生物技術公司正在將數位生物標記納入臨床試驗，以優化患者招募和治療效果評估，從而推動精神病數位生物標記市場的擴張。此外，由於利害關係人強調遵守資料隱私和安全框架，監管發展和對數位健康技術的投資增加也在推動市場動態。

精神病數位生物標記市場的機會在於精準精神病學的發展，精準精神病學使用數位生物標記根據個別患者數據量身定制治療策略。遠距醫療和虛擬心理健康服務的日益普及也為醫療保健提供者創造了將數位監控解決方案整合到遠距治療模式中的市場機會。隨著數位生物標記在監管環境中獲得認可以及報銷框架不斷發展，多模式數據整合和人工智慧驅動的心理健康分析方面的持續技術創新將塑造精神病醫療保健的未來格局，預計市場將經歷強勁增長。

精神病數位生物標記市場：概述

根據類型，穿戴式裝置領域在 2024 年佔據了精神病數位生物標記市場佔有率的主導地位，這得益於先進的生物感測器越來越多地整合到智慧手錶、健身追蹤器和穿戴式 EEG 設備中，以持續監測心理健康。

根據最終用途，醫療保健公司部門在 2024 年佔據了最大的市場佔有率，這得益於精神病數位生物標記在早期診斷中的應用日益增多。

由於該地區擁有先進的醫療保健基礎設施，預計 2024 年北美將在精神病數位生物標記市場中佔據最大的收入佔有率。

由於政府支持心理健康研究的舉措，預計歐洲市場在預測期內將實現最高的複合年增長率。

一些主要的全球公司包括 Biogen、Brainomix、Clario、Empatica、Huma、IXICO plc、Koneksa Health、PureTech Health PLC、Sonde Health 和 VivoSense。

目錄

第一章簡介

第 2 章執行摘要

第三章 分析方法

第 4 章：全球精神病數位生物標記市場洞察

  • 市場概況
  • 數位精神病生物標記的市場動態
    • 推動因素和機遇
      • 精神疾病盛行率不斷上升
      • 穿戴式裝置和行動醫療技術的進步
    • 阻礙因素和課題
      • 資料隱私問題
  • PESTLE 分析
  • 精神病數位生物標記市場的趨勢
  • 價值鏈分析

第五章：全球精神病數位生物標記市場（按類型）

  • 主要發現
  • 簡介
  • 穿戴式裝置
  • 基於行動的應用程式
  • 感測器
  • 其他

6.全球精神病數位生物標記市場（按臨床程序）

  • 主要發現
  • 簡介
  • 診斷性精神病數位生物標記
  • 用於監測的精神科數位生物標記
  • 用於精神病學預測和預後的數字生物標記
  • 其他

7.全球精神病數位生物標記市場（依最終用途）

  • 主要發現
  • 簡介
  • 醫療公司
  • 醫療保健提供者
  • 付款人
  • 其他

8.全球精神病數位生物標記市場（按地區）

  • 主要發現
  • 簡介
    • 精神病數位生物標記市場（按地區）分析（2020-2034）
  • 北美
    • 北美，按類型劃分（2020-2034 年）
    • 北美，依醫療程序分類（2020-2034 年）
    • 北美最終用途（2020-2034 年）
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲各類型（2020-2034 年）
    • 歐洲：依醫療程序分類（2020-2034 年）
    • 歐洲：依最終用途劃分（2020-2034 年）
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 亞太地區按類型劃分（2020-2034 年）
    • 亞太地區：依醫療程序分類（2020-2034 年）
    • 亞太地區最終用途（2020-2034）
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲
    • 中東與非洲：依類型（2020-2034 年）
    • 中東和非洲：依醫療程序劃分（2020-2034 年）
    • 中東和非洲：依最終用途劃分（2020-2034 年）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
    • 拉丁美洲各類型（2020-2034）
    • 拉丁美洲，依醫療程序劃分（2020-2034 年）
    • 拉丁美洲以最終用途劃分（2020-2034 年）
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家

第九章 競爭格局

  • 業務擴張與收購分析
    • 業務擴展
    • 收購
  • 夥伴關係/協作/協議/揭露

第十章公司簡介

  • Biogen
  • Brainomix
  • Clario
  • Empatica Inc.
  • Huma
  • IXICO plc
  • Koneksa Health
  • PureTech Health PLC
  • Sonde Health, Inc.
  • VivoSense
  • Xiamen AJK Technology Co., Ltd.
Product Code: PM5446

The global psychiatric digital biomarkers market size is expected to reach USD 5,543.77 million by 2034, according to a new study by Polaris Market Research. The report "Psychiatric Digital Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Type (Wearable, Mobile-Based Applications, Sensors, and Others), Clinical Practice, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Psychiatric digital biomarkers are objective, quantifiable physiological and behavioral data points collected through digital devices to assess mental health conditions. The psychiatric digital biomarkers market is experiencing significant expansion, driven by advancements in artificial intelligence, wearable health technologies, and mobile-based mental health monitoring. The growing prevalence of psychiatric disorders, including depression, schizophrenia, and anxiety, is fueling psychiatric digital biomarkers market demand, as clinicians and researchers seek data-driven, real-time monitoring tools for accurate diagnosis and treatment personalization. The market growth is further supported by the increasing integration of biosensors in smartwatches, mobile apps, and AI-powered analytics, which enhance remote patient monitoring and clinical decision-making.

The psychiatric digital biomarkers industry trends indicate a shift toward leveraging machine learning algorithms to analyze behavioral patterns, voice biomarkers, and physiological signals, improving predictive accuracy and early intervention capabilities. Additionally, pharmaceutical and biotech companies are incorporating digital biomarkers into clinical trials, optimizing patient recruitment and therapeutic efficacy assessments, thereby driving psychiatric digital biomarkers market expansion. Regulatory advancements and increasing investments in digital health technologies are also encouraging market dynamics as stakeholders focus on ensuring compliance with data privacy and security frameworks.

The psychiatric digital biomarkers market opportunities lie in the development of precision psychiatry, where digital biomarkers are used to tailor treatment strategies based on individual patient data. The increasing adoption of telemedicine and virtual mental health services presents another market opportunity; as healthcare providers integrate digital monitoring solutions into remote care models. As digital biomarkers gain regulatory acceptance and reimbursement frameworks evolve, the market is expected to witness robust growth, with continuous innovation in multimodal data integration and AI-driven mental health analytics shaping the future landscape of psychiatric care.

Psychiatric Digital Biomarkers Market Report Highlights

In terms of type, the wearable segment dominated the psychiatric digital biomarkers market share in 2024, due to the growing integration of advanced biosensors in smartwatches, fitness trackers, and wearable EEG devices for continuous mental health monitoring.

Based on end use, the healthcare companies segment accounted for the largest market share in 2024 due to the increasing adoption of psychiatric digital biomarkers for early diagnosis.

In 2024, North America accounted for the largest share of the psychiatric digital biomarkers market revenue due to the region's advanced healthcare infrastructure.

The Europe market is expected to register the highest CAGR during the forecast period due to government initiatives supporting mental health research.

A few of the global key market players are Biogen; Brainomix; Clario; Empatica Inc.; Huma; IXICO plc; Koneksa Health; PureTech Health PLC; Sonde Health, Inc.; and VivoSense.

Polaris Market Research has segmented the psychiatric digital biomarkers market report on the basis of type, clinical practice, end use, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

  • Wearable
  • Mobile-Based Applications
  • Sensors
  • Others

By Clinical Practice Outlook (Revenue - USD Million, 2020-2034)

  • Diagnostic Psychiatric Digital Biomarkers
  • Monitoring Psychiatric Digital Biomarkers
  • Predictive and Prognostic Psychiatric Digital Biomarkers
  • Others

By End Use Outlook (Revenue - USD Million, 2020-2034)

  • Healthcare Companies
  • Healthcare Providers
  • Payers
  • Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Psychiatric Digital Biomarkers Market Insights

  • 4.1. Psychiatric Digital Biomarkers Market - Market Snapshot
  • 4.2. Psychiatric Digital Biomarkers Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Mental Health Disorders
      • 4.2.1.2. Wearable and Mobile Health Technology Advancements
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data Privacy Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Psychiatric Digital Biomarkers Market Trends
  • 4.6. Value Chain Analysis

5. Global Psychiatric Digital Biomarkers Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • 5.3. Wearable
    • 5.3.1. Global Psychiatric Digital Biomarkers Market, by Wearable, by Region, 2020-2034 (USD Million)
  • 5.4. Mobile based Applications
    • 5.4.1. Global Psychiatric Digital Biomarkers Market, Mobile based Applications, by Region, 2020-2034 (USD Million)
  • 5.5. Sensors
    • 5.5.1. Global Psychiatric Digital Biomarkers Market, by Sensors, by Region, 2020-2034 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Psychiatric Digital Biomarkers Market, by Clinical Practice

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • 6.3. Diagnostic Psychiatric Digital Biomarkers
    • 6.3.1. Global Psychiatric Digital Biomarkers Market, by Diagnostic Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
  • 6.4. Monitoring Psychiatric Digital Biomarkers
    • 6.4.1. Global Psychiatric Digital Biomarkers Market, by Monitoring Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
  • 6.5. Predictive and Prognostic Psychiatric Digital Biomarkers
    • 6.5.1. Global Psychiatric Digital Biomarkers Market, by Predictive and Prognostic Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Psychiatric Digital Biomarkers Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 7.3. Healthcare companies
    • 7.3.1. Global Psychiatric Digital Biomarkers Market, by Healthcare companies, by Region, 2020-2034 (USD Million)
  • 7.4. Healthcare Providers
    • 7.4.1. Global Psychiatric Digital Biomarkers Market, by Healthcare Providers, by Region, 2020-2034 (USD Million)
  • 7.5. Payers
    • 7.5.1. Global Psychiatric Digital Biomarkers Market, by Payers, by Region, 2020-2034 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Psychiatric Digital Biomarkers Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Psychiatric Digital Biomarkers Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Psychiatric Digital Biomarkers Market - North America
    • 8.3.1. North America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.3.2. North America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.3.3. North America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.3.4. Psychiatric Digital Biomarkers Market - US
      • 8.3.4.1. US: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.3.4.2. US: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.3.4.3. US: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.3.5. Psychiatric Digital Biomarkers Market - Canada
      • 8.3.5.1. Canada: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 8.4. Psychiatric Digital Biomarkers Market - Europe
    • 8.4.1. Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.4.2. Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.4.3. Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.4. Psychiatric Digital Biomarkers Market - UK
      • 8.4.4.1. UK: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.5. Psychiatric Digital Biomarkers Market - France
      • 8.4.5.1. France: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.5.2. France: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.5.3. France: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.6. Psychiatric Digital Biomarkers Market - Germany
      • 8.4.6.1. Germany: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.7. Psychiatric Digital Biomarkers Market - Italy
      • 8.4.7.1. Italy: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.8. Psychiatric Digital Biomarkers Market - Spain
      • 8.4.8.1. Spain: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.9. Psychiatric Digital Biomarkers Market - Netherlands
      • 8.4.9.1. Netherlands: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.10. Psychiatric Digital Biomarkers Market - Russia
      • 8.4.10.1. Russia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.11. Psychiatric Digital Biomarkers Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 8.5. Psychiatric Digital Biomarkers Market - Asia Pacific
    • 8.5.1. Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.4. Psychiatric Digital Biomarkers Market - China
      • 8.5.4.1. China: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.4.2. China: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.4.3. China: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.5. Psychiatric Digital Biomarkers Market - India
      • 8.5.5.1. India: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.5.2. India: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.5.3. India: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.6. Psychiatric Digital Biomarkers Market - Malaysia
      • 8.5.6.1. Malaysia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.7. Psychiatric Digital Biomarkers Market - Japan
      • 8.5.7.1. Japan: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.8. Psychiatric Digital Biomarkers Market - Indonesia
      • 8.5.8.1. Indonesia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.9. Psychiatric Digital Biomarkers Market - South Korea
      • 8.5.9.1. South Korea: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.10. Psychiatric Digital Biomarkers Market - Australia
      • 8.5.10.1. Australia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.11. Psychiatric Digital Biomarkers Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 8.6. Psychiatric Digital Biomarkers Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.4. Psychiatric Digital Biomarkers Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.5. Psychiatric Digital Biomarkers Market - UAE
      • 8.6.5.1. UAE: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.6. Psychiatric Digital Biomarkers Market - Israel
      • 8.6.6.1. Israel: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.7. Psychiatric Digital Biomarkers Market - South Africa
      • 8.6.7.1. South Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.8. Psychiatric Digital Biomarkers Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 8.7. Psychiatric Digital Biomarkers Market - Latin America
    • 8.7.1. Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.7.4. Psychiatric Digital Biomarkers Market - Mexico
      • 8.7.4.1. Mexico: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.7.5. Psychiatric Digital Biomarkers Market - Brazil
      • 8.7.5.1. Brazil: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.7.6. Psychiatric Digital Biomarkers Market - Argentina
      • 8.7.6.1. Argentina: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.7.7. Psychiatric Digital Biomarkers Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Biogen
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Brainomix
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Clario
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Empatica Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Huma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. IXICO plc
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Koneksa Health
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. PureTech Health PLC
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sonde Health, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. VivoSense
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Xiamen AJK Technology Co., Ltd.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

  • Table 1 Global Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 2 Global Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 3 Global Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 4 North America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 5 North America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 6 North America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 7 US: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 8 US: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 9 US: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 10 Canada: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 11 Canada: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 12 Canada: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 13 Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 14 Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 15 Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 16 UK: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 17 UK: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 18 UK: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 19 France: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 20 France: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 21 France: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 22 Germany: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 23 Germany: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 24 Germany: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 25 Italy: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 26 Italy: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 27 Italy: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 28 Spain: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 29 Spain: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 30 Spain: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 31 Netherlands: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 32 Netherlands: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 33 Netherlands: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 34 Russia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 35 Russia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 36 Russia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 43 China: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 44 China: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 45 China: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 46 India: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 47 India: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 48 India: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 49 Malaysia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 50 Malaysia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 51 Malaysia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 52 Japan: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 53 Japan: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 54 Japan: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 55 Indonesia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 56 Indonesia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 57 Indonesia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 58 South Korea: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 59 South Korea: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 60 South Korea: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 61 Australia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 62 Australia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 63 Australia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 73 UAE: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 74 UAE: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 75 UAE: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 76 Israel: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 77 Israel: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 78 Israel: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 79 South Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 80 South Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 81 South Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 85 Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 86 Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 87 Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 88 Mexico: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 89 Mexico: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 90 Mexico: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 91 Brazil: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 92 Brazil: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 93 Brazil: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 94 Argentina: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 95 Argentina: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 96 Argentina: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Psychiatric Digital Biomarkers Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Psychiatric Digital Biomarkers Market, by Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Clinical Practice
  • Figure 9. Global Psychiatric Digital Biomarkers Market, by Clinical Practice, 2024 & 2034 (USD Million)
  • Figure 10. Market by End Use
  • Figure 11. Global Psychiatric Digital Biomarkers Market, by End Use, 2024 & 2034 (USD Million)